Abstract
Primary intracranial sarcoma, DICER1-mutant, is a rare central nervous system tumor that predominantly affects children, only occasionally described in adults. We report on a 30-year-old man with a primary high-grade tumor initially diagnosed and treated as glioblastoma/gliosarcoma. Nineteen years later, re-evaluation by DNA methylation profiling together with next generation sequencing led to reclassification of the tumor as primary intracranial sarcoma, DICER1-mutant. Subsequent genetic testing confirmed a germline DICER1 mutation in both the patient and his son. Remarkably, radical resection of the tumor followed by external radiotherapy resulted in an unusually prolonged relapse-free survival, a course that appears unique among reported adult patients with DICER1-sarcoma. This report highlights the critical role of epigenomic profiling in CNS tumors exhibiting atypical clinical behavior, even decades after initial diagnosis, to achieve precise classification and optimize patient management. A brief review of DICER1-mutant sarcoma and DICER1 syndrome is also presented.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
